3Bar Biologics Secures $2M in Funding

3Bar Biologics Inc., a Columbus, OH-based provider of a beneficial microbe delivery system, secured $2M in funding.

Backers included Rev1 Ventures, Maumee Ventures, Ohio TechAngel Funds, Queen City Angels, Carmen Innovations, and SVG Thrive Fund.

The company intends to use the funds to broaden availability of its offering.

Led by Bruce Caldwell, CEO, 3Bar uses naturally occurring microbes to allow farmers to improve the quantity and quality of crop production. Its first commercially available product, Bio-YIELD®, is a patented delivery system that leverages living microorganisms to stimulate a plant’s defense, optimizing the chances for greater yield across a broad range of growing conditions.



Join the discussion